Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omniab Inc (OABI)

Omniab Inc (OABI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 273,515
  • Shares Outstanding, K 143,955
  • Annual Sales, $ 26,390 K
  • Annual Income, $ -62,030 K
  • EBIT $ -53 M
  • EBITDA $ -31 M
  • 60-Month Beta 0.13
  • Price/Sales 10.53
  • Price/Cash Flow N/A
  • Price/Book 1.02

Options Overview Details

View History
  • Implied Volatility 245.98% (+96.37%)
  • Historical Volatility 59.81%
  • IV Percentile 68%
  • IV Rank 19.36%
  • IV High 1,055.70% on 11/12/25
  • IV Low 51.61% on 03/31/25
  • Expected Move (DTE 17) 0.4080 (21.47%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,003
  • Open Int (30-Day) 789
  • Expected Range 1.4920 to 2.3080

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.08
  • Number of Estimates 4
  • High Estimate -0.06
  • Low Estimate -0.10
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6900 +12.43%
on 12/02/25
2.2200 -14.41%
on 12/12/25
+0.0900 (+4.97%)
since 11/28/25
3-Month
1.3000 +46.15%
on 11/05/25
2.2200 -14.41%
on 12/12/25
+0.2900 (+18.01%)
since 09/29/25
52-Week
1.2200 +55.74%
on 05/30/25
4.0200 -52.74%
on 02/20/25
-1.6900 (-47.08%)
since 12/27/24

Most Recent Stories

More News
Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

First and only transgenic chicken platform engineered to express ultralong CDRH3 domains on a human antibody framework broadens therapeutic opportunities beyond conventional antibodies ...

OABI : 1.9000 (-1.55%)
OmniAb to Hold OmniUltra Virtual Investor Event on December 15

OmniAb, Inc. (NASDAQ: OABI) today announced it will hold a virtual investor event to showcase the launch of OmniUltra â„¢ on Monday, December 15, 2025, beginning at 5:00 p.m. Eastern...

OABI : 1.9000 (-1.55%)
AI Spending in Healthcare and Wellness Triples as Personalized Wellness Platforms Scale

Issued on behalf of Aleen Inc. VANCOUVER – Baystreet.ca News Commentary – Healthcare's artificial intelligence transformation is accelerating at unprecedented speed, with AI spending hitting...

OPRX : 12.25 (-1.84%)
CTSH : 85.00 (-0.67%)
CERT : 8.85 (-0.45%)
OABI : 1.9000 (-1.55%)
ALEN-U.CN : 1.4500 (unch)
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors

Agreement is focused on Omni dAbâ„¢ single domain technology OmniAb to receive revenue for discovery services as well as potential equity and royalties

OABI : 1.9000 (-1.55%)
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today

OABI : 1.9000 (-1.55%)
OmniAb to Participate in Three Investor Conferences in November

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three investor conferences during the month of November. 2025...

OABI : 1.9000 (-1.55%)
OmniAb to Report Third Quarter 2025 Financial Results on November 4

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and nine months ended September 30, 2025, after the close of the U.S. financial markets on Tuesday, November 4, 2025, and...

OABI : 1.9000 (-1.55%)
OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

OmniAb, Inc. (NASDAQ: OABI) today announced that management will participate at the H.C. Wainwright 27 th Annual Global Investment Conference taking place September 8-10, 2025 at...

OABI : 1.9000 (-1.55%)
OmniAb Announces $30 Million Private Placement

OmniAb, Inc. (NASDAQ: OABI) today announced it has entered into a definitive securities purchase agreement to issue and sell an aggregate of 21,254,106 shares of its common stock at a price of...

OABI : 1.9000 (-1.55%)
OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today

OABI : 1.9000 (-1.55%)

Business Summary

OmniAb Inc. discovery platform provides pharmaceutical industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. OmniAb Inc., formerly known as Avista Public Acquisition Corp. II, is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 1.9800
2nd Resistance Point 1.9600
1st Resistance Point 1.9300
Last Price 1.9000
1st Support Level 1.8800
2nd Support Level 1.8600
3rd Support Level 1.8300

See More

52-Week High 4.0200
Fibonacci 61.8% 2.9504
Fibonacci 50% 2.6200
Fibonacci 38.2% 2.2896
Last Price 1.9000
52-Week Low 1.2200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar